Efficacy and safety of dasatinib versus imatinib in the East Asian subpopulation of the DASISION trial of newly diagnosed chronic myeloid leukemia in chronic phase

Asian patients with chronic myeloid leukemia (CML) tend to have different characteristics compared with patients from other regions, including younger age and smaller body size. The phase 3, open-label, randomized DASISION trial (NCT00481247), comparing dasatinib 100 mg once daily (QD) (n = 259) wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Chuah, Charles T., Nakamae, Hirohisa, Shen, Zhixiang X., Bradley-Garelik, M. Brigid, Kim, Dong-Wook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Informa Healthcare 2014
Materias:
Original Article: Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196520/
https://www.ncbi.nlm.nih.gov/pubmed/24289108
http://dx.doi.org/10.3109/10428194.2013.866663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196520/
https://www.ncbi.nlm.nih.gov/pubmed/24289108
http://dx.doi.org/10.3109/10428194.2013.866663

Ejemplares similares